Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luxin Yang

Showing results (51-60 of 57) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 57 results.
Annals of Hematology|October 24, 2025
Developmental stage modulates the prognostic impact of RAS pathway mutations in AML patients undergoing Allo-HSCTXiaolin Yuan, Yibo Wu, Yanan Wang, et al.
Cancer|February 5, 2024
Comparison of long-term outcomes between imatinib and dasatinib prophylaxis after allogeneic stem cell transplantation in patients with Philadelphia-positive acute lymphoblastic leukemia: A multicenter retrospective studyFangshu Guan, Luxin Yang, Yi Chen, et al.
Annals of Hematology|July 4, 2024
Impact of additional cytogenetic aberrations at diagnosis on prognosis of adults patients with Philadelphia chromosome positive acute lymphoblastic leukemia undergoing allogeneic hematopoietic cell transplantation: a retrospective analysisJing Zheng, Yanmin Zhao, Yi Luo, et al.
Bone Marrow Transplantation|November 1, 2023
Prophylactic versus Preemptive modified donor lymphocyte infusion for high-risk acute leukemia after allogeneic hematopoietic stem cell transplantation: a multicenter retrospective studyLuxin Yang, Xiaoyu Lai, Ting Yang, et al.
Annals of Hematology|January 22, 2025
Adult patients with Philadelphia chromosome positive acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantation and tyrosine kinase inhibitors: development and validation of a clinical prediction model based on cytogenetics, IKZF1 deletions and minimal residual diseaseJing Zheng, Yuping Zhou, Yanmin Zhao, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 1, 2023
Liposomal AntagomiR-155-5p Restores Anti-Inflammatory Macrophages and Improves Arthritis in Preclinical Models of Rheumatoid ArthritisAudrey Paoletti, Bineta Ly, Catherine Cailleau, et al.
British Journal of Haematology|June 11, 2025
EASIX score predicts non-relapse mortality and severe infection in elderly patients undergoing allo-HSCTLizhen Liu, Shipei Xiang, Junjie Cao, et al.
Pageof 6

Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
Annals of Hematology|October 24, 2025
Developmental stage modulates the prognostic impact of RAS pathway mutations in AML patients undergoing Allo-HSCTXiaolin Yuan, Yibo Wu, Yanan Wang, et al.
Cancer|February 5, 2024
Comparison of long-term outcomes between imatinib and dasatinib prophylaxis after allogeneic stem cell transplantation in patients with Philadelphia-positive acute lymphoblastic leukemia: A multicenter retrospective studyFangshu Guan, Luxin Yang, Yi Chen, et al.
Annals of Hematology|July 4, 2024
Impact of additional cytogenetic aberrations at diagnosis on prognosis of adults patients with Philadelphia chromosome positive acute lymphoblastic leukemia undergoing allogeneic hematopoietic cell transplantation: a retrospective analysisJing Zheng, Yanmin Zhao, Yi Luo, et al.
Bone Marrow Transplantation|November 1, 2023
Prophylactic versus Preemptive modified donor lymphocyte infusion for high-risk acute leukemia after allogeneic hematopoietic stem cell transplantation: a multicenter retrospective studyLuxin Yang, Xiaoyu Lai, Ting Yang, et al.
Annals of Hematology|January 22, 2025
Adult patients with Philadelphia chromosome positive acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantation and tyrosine kinase inhibitors: development and validation of a clinical prediction model based on cytogenetics, IKZF1 deletions and minimal residual diseaseJing Zheng, Yuping Zhou, Yanmin Zhao, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 1, 2023
Liposomal AntagomiR-155-5p Restores Anti-Inflammatory Macrophages and Improves Arthritis in Preclinical Models of Rheumatoid ArthritisAudrey Paoletti, Bineta Ly, Catherine Cailleau, et al.
British Journal of Haematology|June 11, 2025
EASIX score predicts non-relapse mortality and severe infection in elderly patients undergoing allo-HSCTLizhen Liu, Shipei Xiang, Junjie Cao, et al.
Pageof 6